JP2025500860A5 - - Google Patents
Info
- Publication number
- JP2025500860A5 JP2025500860A5 JP2024535520A JP2024535520A JP2025500860A5 JP 2025500860 A5 JP2025500860 A5 JP 2025500860A5 JP 2024535520 A JP2024535520 A JP 2024535520A JP 2024535520 A JP2024535520 A JP 2024535520A JP 2025500860 A5 JP2025500860 A5 JP 2025500860A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- dsrna
- antisense strand
- sense strand
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111542797.4 | 2021-12-16 | ||
| CN202111542797 | 2021-12-16 | ||
| PCT/CN2022/139488 WO2023109938A1 (zh) | 2021-12-16 | 2022-12-16 | 一种dsRNA、其制备方法及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500860A JP2025500860A (ja) | 2025-01-15 |
| JP2025500860A5 true JP2025500860A5 (https=) | 2025-12-26 |
Family
ID=86774893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535520A Pending JP2025500860A (ja) | 2021-12-16 | 2022-12-16 | ｄｓＲＮＡ、その調製方法及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP2025500860A (https=) |
| KR (1) | KR20240116537A (https=) |
| CN (1) | CN118302526A (https=) |
| CA (1) | CA3240651A1 (https=) |
| TW (1) | TW202334425A (https=) |
| WO (1) | WO2023109938A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024125636A1 (zh) * | 2022-12-16 | 2024-06-20 | 上海拓界生物医药科技有限公司 | Toll样受体调节剂与dsRNA的联合治疗 |
| CN119816597A (zh) * | 2023-08-10 | 2025-04-11 | 石药集团中奇制药技术（石家庄）有限公司 | 一种抑制HBV基因表达的dsRNA分子及其应用 |
| CN116854754B (zh) | 2023-09-01 | 2023-12-12 | 北京悦康科创医药科技股份有限公司 | 一种含有核糖环或其衍生结构的GalNAc化合物及其寡核苷酸缀合物 |
| CN118638166B (zh) | 2024-08-15 | 2024-12-17 | 北京悦康科创医药科技股份有限公司 | 含有三氮唑结构的GalNAc化合物及其寡核苷酸缀合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101773551B1 (ko) * | 2008-10-15 | 2017-08-31 | 아이오니스 파마수티컬즈, 인코포레이티드 | 인자 １１ 발현의 조정 |
| EA024762B9 (ru) * | 2011-06-30 | 2017-04-28 | Эрроухэд Рисерч Корпорейшн | Композиции и способы ингибирования экспрессии генов вируса гепатита в |
| EP3719127A4 (en) * | 2017-12-01 | 2021-10-20 | Suzhou Ribo Life Science Co., Ltd. | NUCLEIC ACID, COMPOSITION AND CONJUGATE WITH IT, MANUFACTURING METHOD AND USE |
| CN111378655B (zh) * | 2018-12-28 | 2024-03-19 | 苏州瑞博生物技术股份有限公司 | 抑制CTGF基因表达的siRNA、含有该siRNA的药物组合物及其用途 |
| AU2020280439B2 (en) * | 2019-05-22 | 2025-08-14 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
| KR20220011689A (ko) * | 2019-05-22 | 2022-01-28 | 쑤저우 리보 라이프 사이언스 컴퍼니, 리미티드 | 핵산, 약제학적 조성물, 접합체, 제조 방법, 및 용도 |
-
2022
- 2022-12-16 CN CN202280076303.4A patent/CN118302526A/zh active Pending
- 2022-12-16 CA CA3240651A patent/CA3240651A1/en active Pending
- 2022-12-16 KR KR1020247022568A patent/KR20240116537A/ko active Pending
- 2022-12-16 TW TW111148551A patent/TW202334425A/zh unknown
- 2022-12-16 JP JP2024535520A patent/JP2025500860A/ja active Pending
- 2022-12-16 WO PCT/CN2022/139488 patent/WO2023109938A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7625637B2 (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| JP2025500860A5 (https=) | ||
| JP7442574B2 (ja) | Ｌｐａの遺伝子発現の阻害のための組成物及び方法 | |
| JP7763907B2 (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| CN108136206B (zh) | 抗乙型肝炎病毒的组合物和药剂及其用途 | |
| CN108026533B (zh) | 拮抗性pdl1适体及其在癌症治疗中的应用 | |
| TWI881004B (zh) | 用於治療ｈｂｖ之靶向ｈｂｖ的治療性寡核苷酸及ｔｌｒ７促效劑之醫藥組合 | |
| TWI762732B (zh) | 用於降低PAPD5及PAPD7 mRNA以治療B型肝炎感染之核酸分子 | |
| CN113750112A (zh) | 治疗b型肝炎和d型肝炎病毒感染的方法 | |
| TW202103698A (zh) | 用於治療b型肝炎病毒感染之組合療法 | |
| JP2024544532A5 (https=) | ||
| CN118284695A (zh) | 用于治疗hbv的药物组合 | |
| JP2021524277A (ja) | Ｒｔｅｌ１発現の調節用のオリゴヌクレオチド | |
| CN114057816B (zh) | 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用 | |
| HK40062579A (en) | Rnai agents for hepatitis b virus infection | |
| HK40110728A (zh) | 用於治疗hbv的药物组合 | |
| WO2025067544A1 (zh) | 用于抑制乙型肝炎病毒的siRNA及其用途 | |
| HK40009627B (en) | Rnai agents for hepatitis b virus infection | |
| HK40065449A (en) | Methods for the treatment of hepatitis b and hepatitis d virus infections | |
| JPWO2021020412A5 (https=) | ||
| HK40009627A (en) | Rnai agents for hepatitis b virus infection |